Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities
- 31 May 1988
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 155 (5) , 667-671
- https://doi.org/10.1016/s0002-9610(88)80140-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1‐phenylalanine mustardJournal of Surgical Oncology, 1987
- Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomyThe American Journal of Surgery, 1986
- Toxicity and complications of vascular isolation and hyperthermic perfusion with lmidazole carboxamide (DTIC) in melanomaCancer, 1986
- The Treatment of Stage I Melanoma of the Extremities with Regional Hyperthermic Isolation PerfusionAnnals of Surgery, 1982
- The Surgical Treatment and Outcome of Soft-Tissue SarcomaArchives of Surgery, 1981
- Surgical Treatment of 297 Soft Tissue Sarcomas of the Lower ExtremityAnnals of Surgery, 1975
- Soft Tissue SarcomasAnnals of Surgery, 1975
- Chemotherapy of Melanoma of the Extremities by PerfusionAnnals of Surgery, 1972
- Experience with 1-phenylalanine mustard dihydrochloride in isolation-perfusion of extremities for malignant melanomaCancer, 1971
- The Problem of Local Recurrence after Treatment of Soft Tissue SarcomaAnnals of Surgery, 1968